Preoperative Exposure to Oral First-Generation Cephalosporins and Periprosthetic Joint Infection: A Cautionary Association in the U.S. Population Level

Background While patient-specific risk factors for periprosthetic joint infection (PJI) are well-defined, the impact of recent antibiotic exposure as a marker of infection vulnerability remains unclear. This study evaluated whether recent preoperative exposure to oral first-generation cephalosporins (OFGCs) is associated with increased PJI risk following elective total joint arthroplasty (TJA). Methods We performed a retrospective study using a national database. Exposure was receiving OFGCs for nonmusculoskeletal indications within 1-year preoperatively. Patients undergoing elective primary TJA were propensity-matched 1:1 to unexposed patients (N = 247,207) by age, sex, Charlson Comorbidity Index, obesity, diabetes, and smoking. Outcomes were surgical procedures for PJI and all-cause revision at 90 days and 1-year. Results OFGC exposure was associated with higher PJI incidence at 90 days (1.49% vs 1.10%, OR 1.35, 95% CI 1.29-1.41, P < .0001) and 1-year (2.59% vs 1.89%, OR 1.39, 95% CI 1.34-1.44, P < .0001). Exposed patients had higher rates of PJI-related surgical procedures at 90 days (1.09% vs 0.78%, OR 1.39, 95% CI 1.32-1.46, P < .0001) and 1-year (1.89% vs 1.32%, OR 1.44, 95% CI 1.38-1.51, P < .0001). PJI rates remained higher across infection indications. Neither vancomycin cefazolin prophylaxis nor postoperative EOA mitigated this association. Conclusions Recent OFGC exposure was a marker of increased PJI risk following elective primary TJA, regardless of antibiotic indication. This association may reflect underlying patient or healthcare-related factors rather than a direct antibiotic effect. Future studies should determine whether OFGC exposure not only identifies higher-risk patients but also influences the microbiological and clinical course of PJI. Level of Evidence Level III.

Authors

Institutions

Publication Details

Journal
Arthroplasty Today
Published
2026-11-18
DOI
https://doi.org/10.1016/j.artd.2026.102211
Primary Topic
Orthopedic Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Preoperative Exposure to Oral First-Generation Cephalosporins and Periprosthetic Joint Infection: A Cautionary Association in the U.S. Population Level

Erik N. Hansen, Jessica L Abrolat, Ahmad M. Zedan, Claudio Díaz-Ledezma et al.
3 links
Arthroplasty Today
Orthopedic Infections and Treatments
article

Preoperative Exposure to Oral First-Generation Cephalosporins and Periprosthetic Joint Infection: A Cautionary Association in the U.S. Population Level

Erik N. Hansen, Jessica L Abrolat, Ahmad M. Zedan, Claudio Díaz-Ledezma, Arezo Ebne Ahmadi
article en

Abstract

Background While patient-specific risk factors for periprosthetic joint infection (PJI) are well-defined, the impact of recent antibiotic exposure as a marker of infection vulnerability remains unclear. This study evaluated whether recent preoperative exposure to oral first-generation cephalosporins (OFGCs) is associated with increased PJI risk following elective total joint arthroplasty (TJA). Methods We performed a retrospective study using a national database. Exposure was receiving OFGCs for nonmusculoskeletal indications within 1-year preoperatively. Patients undergoing elective primary TJA were propensity-matched 1:1 to unexposed patients (N = 247,207) by age, sex, Charlson Comorbidity Index, obesity, diabetes, and smoking. Outcomes were surgical procedures for PJI and all-cause revision at 90 days and 1-year. Results OFGC exposure was associated with higher PJI incidence at 90 days (1.49% vs 1.10%, OR 1.35, 95% CI 1.29-1.41, P < .0001) and 1-year (2.59% vs 1.89%, OR 1.39, 95% CI 1.34-1.44, P < .0001). Exposed patients had higher rates of PJI-related surgical procedures at 90 days (1.09% vs 0.78%, OR 1.39, 95% CI 1.32-1.46, P < .0001) and 1-year (1.89% vs 1.32%, OR 1.44, 95% CI 1.38-1.51, P < .0001). PJI rates remained higher across infection indications. Neither vancomycin cefazolin prophylaxis nor postoperative EOA mitigated this association. Conclusions Recent OFGC exposure was a marker of increased PJI risk following elective primary TJA, regardless of antibiotic indication. This association may reflect underlying patient or healthcare-related factors rather than a direct antibiotic effect. Future studies should determine whether OFGC exposure not only identifies higher-risk patients but also influences the microbiological and clinical course of PJI. Level of Evidence Level III.

Arthroplasty TodayVol. 42
University of California, San Francisco (US), University of California San Francisco Medical Center (US)
Good health and well-being
Orthopedic Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon